Abstract
BackgroundImplantable cardioverter defibrillators (ICDs), used alone, or sometimes combined with pacemaker-based cardiac resynchronisation therapy, are increasingly inserted to treat those with heart failure (HF) at risk of lethal arrhythmias. Device...
Published Version (
Free)
Join us for a 30 min session where you can share your feedback and ask us any queries you have